12 results on '"Barcheni M"'
Search Results
2. Biplanar vs uniplanar pedicle subtraction osteotomy for rigid adult spinal deformity: Trading safety for correction?
- Author
-
Vila, L., primary, Haddad, S., additional, Núñez-Pereira, S., additional, Ramirez, V.M., additional, Capdevila, B.M., additional, Barcheni, M., additional, Pizones, J., additional, Pérez-Grueso, F.J., additional, Obeid, I., additional, Alanay, A., additional, Kleinstück, F., additional, Pellise, F., additional, and Essg, E.S.S.G., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Long term mechanical failure in well aligned adult spinal deformity patients
- Author
-
Haddad, S., primary, Núñez-Pereira, S., additional, Ramirez, V.M., additional, Barcheni, M., additional, Pizones, J., additional, Yilgor, C., additional, Alanay, A., additional, Obeid, I., additional, Pérez-Grueso, F.J., additional, Kleinstück, F., additional, Pellise, F., additional, and Essg, E.S.S.G., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Digitized radiographs outperform radiographic measurements in predicting mechanical complications in adult spinal deformity
- Author
-
Barcheni, M., primary, Kakeh, N., additional, Capdevila, B.M., additional, Núñez-Pereira, S., additional, Haddad, S., additional, Ramirez, V.M., additional, Pizones, J., additional, Pérez-Grueso, F.J., additional, Obeid, I., additional, Kleinstück, F., additional, Alanay, A., additional, Galbusera, F., additional, Yilgor, C., additional, Mannion, A.F., additional, Pellise, F., additional, and Essg, E.S.S.G., additional
- Published
- 2023
- Full Text
- View/download PDF
5. Placebo response and its predictors in Attention Deficit Hyperactivity Disorder: a meta-analysis and comparison of meta-regression and MetaForest
- Author
-
Castells X, Saez M, Barcheni M, Cunill R, Serrano D, López B, and van Lissa C
- Subjects
MetaForest ,meta-analysis ,Attention Deficit Hyperactivity Disorder ,machine learning ,meta-regression ,placebo response - Abstract
BACKGROUND: High placebo response in ADHD can reduce medication-placebo differences, jeopardizing the development of new medicines. This research aims to 1) determine placebo response in ADHD, 2) compare the accuracy of meta-regression and MetaForest in predicting placebo response, and 3) determine the covariates associated with placebo response. METHODS: A systematic review with meta-analysis (SRMA) of RPCCTs investigating pharmacological interventions for ADHD was performed. Placebo response was defined as the change from baseline in ADHD symptom severity assessed according to the 18-item, clinician-rated, DSM-based rating scale. The effect of study design-, intervention- and patient-related covariates in predicting placebo response was studied by means of meta-regression and MetaForest. RESULTS: Ninety-four studies including 6,614 patients randomized to placebo were analysed. Overall, placebo response was -8.9 points, representing a 23.1% reduction in the severity of ADHD symptoms. Cross-validated accuracy metrics for meta-regression were R 2 = 0.0012 and RMSE = 3.3219 for meta-regression and 0.0382 and 3.2599 for MetaForest. Placebo response amongst ADHD patients increased by 63% between 2001 and 2020 and was larger in the US than in other regions of the world. CONCLUSIONS: Strong placebo response was found in ADHD patients. Both meta-regression and MetaForest showed poor performance in predicting placebo response. ADHD symptom improvement with placebo has markedly increased over the last two decades and is grater in the US than the rest of the world.
- Published
- 2022
6. Impact of Deep Surgical Site Infection on Adult Spinal Deformity PROMs
- Author
-
Vila, L., Núñez-Pereira, S., Haddad, S., Linares, J.F. Salom, Ramirez, M., Garcia, D.F.A., Jacobs, E., Barcheni, M., Perez-Grueso, F. Sanchez, Pizones, J., Obeid, I., Kleinstück, F., Alanay, A., Pellise, F., and Essg, E.S.S.G.
- Published
- 2024
- Full Text
- View/download PDF
7. Navigating Thoracolumbar Curve Treatment in Midlife: a Critical Decision Point
- Author
-
Haddad, S., Núñez-Pereira, S., Pizones, J., Pupak, A., Vila, L., Ramirez, M., Gomez-Rice, A., Charles, Y.P., Alanay, A., Barcheni, M., Obeid, I., Kleinstück, F., Perez-Grueso, F. Sanchez, Pellise, F., and Essg, E.S.S.G.
- Published
- 2024
- Full Text
- View/download PDF
8. Placebo Response and Its Predictors in Attention Deficit Hyperactivity Disorder: A Meta-Analysis and Comparison of Meta-Regression and MetaForest
- Author
-
Castells, Xavier, Saez, Marc, Barcheni, Maghie, Cunill, Ruth, Serrano, Domènec, López, Beatriz, van Lissa, Caspar, Leerstoel Heijden, Methodology and statistics for the behavioural and social sciences, Leerstoel Heijden, Methodology and statistics for the behavioural and social sciences, [Castells X] Grup de recerca TransLab, Departament de Ciències Mèdiques, Universitat de Girona, Girona, Spain. [Saez M] Grup de Recerca en Estadística, Econometria i Salut (GRECS), Universitat de Girona, Girona, Spain. Centro de Red de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Barcheni M] Departament de Farmacologia, Toxicologia i Terapèutica. Universitat Autònoma de Barcelona, Barcelona, Spain. [Cunill R] Parc Sanitari Sant Joan de Déu-Numància, Parc Sanitari Sant Joan de Déu, Barcelona, Spain. [Serrano D] Institut d'Assistència Sanitària, Salt, Spain. [López B] Grup de Recerca en Enginyeria de Sistemes Intel·ligents i de Control, Departament d'Enginyeria Elèctrica, Electrònica i Automàtica, Universitat de Girona, Girona, Spain. [Van Lissa C] Department of Methodology and Statistics, Universiteit Utrecht, The Netherlands, and Institut d'Assistència Sanitària
- Subjects
Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Regression Analysis [HEALTH CARE] ,Adult ,Male ,medicine.medical_specialty ,Attention Deficit Hyperactivity Disorder ,Adolescent ,AcademicSubjects/MED00415 ,Placebo response ,características del estudio::estudio clínico::ensayo clínico::ensayo clínico controlado::ensayo clínico controlado aleatorizado [CARACTERÍSTICAS DE PUBLICACIONES] ,Study Characteristics::Clinical Study::Clinical Trial::Controlled Clinical Trial::Randomized Controlled Trial [PUBLICATION CHARACTERISTICS] ,Placebo ,Regular Research Articles ,Medicina -- Investigació -- Avaluació ,Mental Disorders::Neurodevelopmental Disorders::Attention Deficit and Disruptive Behavior Disorders::Attention Deficit Disorder with Hyperactivity [PSYCHIATRY AND PSYCHOLOGY] ,Rating scale ,Internal medicine ,meta-regression ,Medicine -- Research -- Evaluation ,Medicine ,Attention deficit hyperactivity disorder ,Humans ,Pharmacology (medical) ,Meta-regression ,Attention-deficit hiperactivity disorder ,Adhd symptoms ,Randomized Controlled Trials as Topic ,Pharmacology ,business.industry ,AcademicSubjects/SCI01870 ,medicine.disease ,Placebo Effect ,United States ,MetaForest ,meta-analysis ,Psychiatry and Mental health ,Trastorn per dèficit d'atenció amb hiperactivitat ,Pharmacological interventions ,Treatment Outcome ,machine learning ,Attention Deficit Disorder with Hyperactivity ,Meta-analysis ,calidad, acceso y evaluación de la atención sanitaria::calidad de la atención sanitaria::mecanismos de evaluación de la atención sanitaria::estadística como asunto::análisis de regresión [ATENCIÓN DE SALUD] ,Assaigs clínics - Mètodes estadístics ,Central Nervous System Stimulants ,placebo response ,trastornos mentales::trastornos del desarrollo neurológico::trastornos conductuales disruptivos y déficit de atención::trastornos de déficit de atención con hiperactividad [PSIQUIATRÍA Y PSICOLOGÍA] ,business ,Metaanàlisi - Abstract
Background High placebo response in attention deficit hyperactivity disorder (ADHD) can reduce medication–placebo differences, jeopardizing the development of new medicines. This research aims to (1) determine placebo response in ADHD, (2) compare the accuracy of meta-regression and MetaForest in predicting placebo response, and (3) determine the covariates associated with placebo response. Methods A systematic review with meta-analysis of randomized, placebo-controlled clinical trial investigating pharmacological interventions for ADHD was performed. Placebo response was defined as the change from baseline in ADHD symptom severity assessed according to the 18-item, clinician-rated, DSM-based rating scale. The effect of study design–, intervention–, and patient–related covariates in predicting placebo response was studied by means of meta-regression and MetaForest. Results Ninety-four studies including 6614 patients randomized to placebo were analyzed. Overall, placebo response was −8.9 points, representing a 23.1% reduction in the severity of ADHD symptoms. Cross-validated accuracy metrics for meta-regression were R2 = 0.0012 and root mean squared error = 3.3219 for meta-regression and 0.0382 and 3.2599 for MetaForest. Placebo response among ADHD patients increased by 63% between 2001 and 2020 and was larger in the United States than in other regions of the world. Conclusions Strong placebo response was found in ADHD patients. Both meta-regression and MetaForest showed poor performance in predicting placebo response. ADHD symptom improvement with placebo has markedly increased over the last 2 decades and is greater in the United States than the rest of the world.
- Published
- 2021
9. Long-term mechanical failure in well aligned adult spinal deformity patients.
- Author
-
Haddad S, Yilgor C, Jacobs E, Vila L, Nuñez-Pereira S, Ramirez Valencia M, Pupak A, Barcheni M, Pizones J, Alanay A, Kleinstuck F, Obeid I, and Pellisé F
- Subjects
- Humans, Middle Aged, Male, Female, Aged, Retrospective Studies, Reoperation statistics & numerical data, Kyphosis surgery, Spinal Fusion methods, Spinal Fusion adverse effects, Risk Factors, Spinal Curvatures surgery, Postoperative Complications epidemiology, Postoperative Complications etiology
- Abstract
Background Context: Mechanical complications (MC) are frequently linked to suboptimal postoperative alignment and represent a primary driver of revision surgery in the context of adult spinal deformity (ASD). However, it's worth noting that even among those deemed "well aligned," the risk of experiencing MCs persists, hinting at the potential influence of factors beyond alignment., Purpose: The aim was to assess the incidence of MCs among well-aligned patients and delving into the relevant risk factors and surgical outcomes that come into play within this specific subgroup., Study Design/setting: A retrospective analysis was conducted using data from a prospective multicenter database dedicated to ASD., Patient Sample: The study focused on patients aged 55 years or older, who had a minimum follow-up period of 2 years, and exhibited a Global Alignment and Proportion (GAP) score of 2 points or less (excluding age) within 6 weeks of their index surgery., Outcome Measures: Mechanical complications such as rod fractures, pseudarthrosis, or junctional kyphosis or failure., Methods: Patients who developed mechanical complications were identified. Comparative analyses were performed, encompassing both continuous and categorical variables. Furthermore, binary logistic regression tests were employed to pinpoint risk factors, and ROC curves were used to determine the optimal threshold values for these variables., Results: A total of 83 patients met the inclusion criteria for this study, with a mean age of 66 years. On average, they had 10 instrumented levels, and 77% of them had fusion extending to the pelvis. Additionally, 27% of the patients had undergone 3-column osteotomies (3-CO). Among them, 33 patients (40%) experienced at least 1 MC during an average follow-up period of 4 years, which included 14 cases of proximal junctional kyphosis (PJK) and 20 cases of nonunion or rod breakage. 15 patients (18%) required revision surgery specifically for MC. In univariable analyses, patients who developed MC were characterized by higher body weight, poorer baseline general health (as indicated by worse SF-36 scores), and less favorable preoperative coronal and sagittal alignment. They also had longer hospital stays, a greater number of instrumented levels, and achieved less favorable postoperative coronal and sagittal alignment. Interestingly, factors such as 3-column osteotomies, postoperative bracing, and the addition of an anterior approach did not significantly alter the risk of MC in well-aligned ASD patients. Binary regression models revealed that independent risk factors for MC included the residual coronal lumbosacral curve, the number of instrumented levels, and relative spinopelvic alignment (RSA). ROC curves identified an optimal threshold of a residual lumbosacral curve of ≤4° and RSA of ≤3°. Moreover, the rate of MCs showed a stepwise increase within the GAP-Proportioned group, with rates of 31% for GAP=0, 54% for GAP=1, and 75% for GAP=2, with RSA emerging as the most influential parameter. Lastly, patients with MC exhibited poorer functional and radiological outcomes at their last follow-up assessment., Conclusions: The rate of MCs remains elevated in sagittally "well-aligned" ASD patients that can be attributed to suboptimal residual sagittal and coronal malalignment, which in turn leads to poorer functional outcomes. This study reaffirms the multifaceted nature of MCs and underscores the significance of achieving impeccable postoperative alignment, particularly in the presence of additional risk factors such as extensive surgical correction, a high lever arm (involving instrumented vertebrae), excessive body weight, and frailty (as indicated by SF-36 scores)., Competing Interests: Declarations of competing interests One or more of the authors declare financial or professional relationships on ICMJE-TSJ disclosure forms., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
10. Long-Term Loss of Alignment Following ASD Surgery in the Absence of Mechanical Complications: Aging Spine?
- Author
-
Haddad S, Jacobs E, Núñez Pereira S, Ruiz de Villa A, Pupak A, Barcheni M, Ramírez Valencia M, Pizones J, Kleinstück FS, Pérez Grueso FS, Alanay A, Obeid I, and Pellisé F
- Abstract
Study Design: Retrospective analysis of a prospective multicenter Adult Spinal Deformity (ASD) registry., Objective: Assess whether spinal alignment deteriorates post-surgery in absence of mechanical complications and evaluate the long-term outcomes of ASD surgery over a five-year period., Summary of Background Data: ASD is prevalent among older adults, leading to significant pain and disability. Surgical intervention, although increasingly popular, is associated with complications, high costs, and uncertain long-term outcomes beyond two years. Mechanical failure and alignment loss often necessitate revision surgeries, but the natural progression of spinal alignment post-surgery without complications remains unclear., Methods: Clinical and radiological data were analyzed from surgical patients in a multicenter ASD registry who maintained alignment within the instrumented region and completed a 5-year follow-up. The study evaluated patient demographics, surgical details, radiological parameters, and quality of life (QoL) outcomes. Sub-analyses were conducted to compare patients with different initial postoperative alignments and fixation levels., Results: The study included 79 patients (83.5% women, average age 61.9 years) with a mean of 10.7 fused levels. Of these, 29.1% underwent three-column osteotomies (3CO), and 88.6% had a posterior-only approach. While 65% showed favorable alignment at 6 weeks post-surgery, there was a progressive deterioration in global sagittal alignment (Global Tilt/RSA) and thoracic kyphosis over five years (P<0.05), along with increased pelvic compensation (PT SS/RPV). These changes did not correlate with worsening Health-Related Quality of Life outcomes (P>0.05). Older age was linked to greater progression in T2-T12 kyphosis, and osteoporosis was associated with increased SVA and RPV. Optimal immediate postoperative sagittal alignment did not prevent this "aging effect.", Conclusions: ASD surgery and achieving ideal postoperative alignment do not prevent the ongoing "aging" of the non-instrumented spine. Both thoracic and global sagittal alignments deteriorate over time. Although no functional decline has been observed, the implications of these changes for surgical planning remain uncertain., Competing Interests: Conflict of Interests: The European Spine Study Group receives funding support from DePuy Synthes and Medtronic., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. The Impact of Unplanned Reoperation Following Adult Spinal Deformity Surgery: A Prospective Longitudinal Cohort Study with 5-Year Follow-up.
- Author
-
Pellisé F, Bayo MC, Ruiz de Villa A, Núñez-Pereira S, Haddad S, Barcheni M, Pizones J, Valencia MR, Obeid I, Alanay A, Kleinstueck FS, and Mannion AF
- Subjects
- Adult, Humans, Reoperation, Follow-Up Studies, Longitudinal Studies, Prospective Studies, Quality of Life
- Abstract
Background: The long-term impact of reoperations following adult spinal deformity (ASD) surgery is still poorly understood. Our aim was to identify the relationship between unplanned reoperation and health-related quality of life (HRQoL) gain at 2 and 5 years of follow-up., Methods: We included patients enrolled in a prospective ASD database who underwent surgery ≥5 years prior to the start of the study and who had 2 years of follow-up data. Adverse events (AEs) leading to an unplanned reoperation, the time of reoperation occurrence, invasiveness (blood loss, surgical time, hospital stay), and AE resolution were assessed. HRQoL was measured with use of the Oswestry Disability Index, Scoliosis Research Society-22, and Short Form-36. Linear models controlling for baseline data and index surgery characteristics were utilized to assess the relationships between HRQoL gain at 2 and 5-year follow-up and the number and invasiveness of reoperations. The association between 5-year HRQoL gain and the time of occurrence of the unplanned reoperation and that between 5-year HRQoL gain and AE resolution were also investigated., Results: Of 361 eligible patients, 316 (87.5%) with 2-year follow-up data met the inclusion criteria and 258 (71.5%) had 5-year follow-up data. At the 2-year follow-up, 96 patients (30.4%) had a total of 165 unplanned reoperations (1.72 per patient). At the 5-year follow-up, 73 patients (28.3%) had a total of 117 unplanned reoperations (1.60 per patient). The most common cause of reoperations was mechanical complications (64.9%), followed by surgical site infections (15.7%). At the 5-year follow-up, the AE that led to reoperation was resolved in 67 patients (91.8%). Reoperation invasiveness was not associated with 5-year HRQoL scores. The number of reoperations was associated with lesser HRQoL gain at 5 years for all HRQoL measures. The mean associated reduction in HRQoL gain per unplanned reoperation was 41% (range, 19% to 66%). Reoperations resulting in no resolution of the AE or resolution with sequelae had a greater impact on 5-year follow-up HRQoL scores than reoperations resulting in resolution of the AE., Conclusions: A postoperative, unplanned reoperation following ASD surgery was associated with lesser gain in HRQoL at 5 years of follow-up. The association did not diminish over time and was affected by the number, but not the magnitude, of reoperations. Resolution of the associated AE reduced the impact of the unplanned reoperation., Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence., Competing Interests: Disclosure: This study was funded in part by DePuy Spine Synthes, Medtronic, and NuVasive research grants. The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article (http://links.lww.com/JBJS/H872)., (Copyright © 2024 by The Journal of Bone and Joint Surgery, Incorporated.)
- Published
- 2024
- Full Text
- View/download PDF
12. Nocebo Response in Attention Deficit Hyperactivity Disorder: Meta-Analysis and Meta-Regression of 105 Randomized Clinical Trials.
- Author
-
Ramírez-Saco D, Barcheni M, Cunill R, Sáez M, Farré M, and Castells X
- Subjects
- Double-Blind Method, Humans, Randomized Controlled Trials as Topic, Attention Deficit Disorder with Hyperactivity drug therapy, Nocebo Effect
- Abstract
Objective: To determine nocebo response in ADHD, identify covariates modifying nocebo response, and study the relationship between nocebo response and drug safety., Method: Systematic review of randomized, double-blind, placebo-controlled clinical trials (RCT) investigating the efficacy and safety of pharmacological interventions for ADHD patients. The influence of covariates was studied using meta-regression., Results: A total of 105 studies with 8,743 patients in placebo arms were included. Slightly over half (55.5%) of the patients experienced adverse events (AE) while receiving placebo. Nocebo response was associated positively with age, treatment length and method for collecting AEs. Studies with the largest nocebo response showcased the greatest drug response and the best outcome for drug safety., Conclusion: Nocebo response in ADHD RCTs is remarkable, showing a positive relationship with drug response, and a negative relationship with drug safety.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.